| payload |
{"created_at":"2026-04-16T02:08:52.472 {"created_at":"2026-04-16T02:08:52.472606+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:c10d6e151d4cea48","evidence_event_ids":["evt_5607989a08ad"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","as_of":"2026-04-16T02:08:52.472606+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","company":"Traws Pharma, Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","article_chars":5000,"article_truncated":true,"blocked_reason":null,"candidate_id":"sc_f89c55d0ae0145cb","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","content_type":"text/plain","enriched_at":"2026-04-16T02:29:29.543952+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"Traws Pharma, Inc._December 31, 2025","final_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","html_truncated":true,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt","source_event_id":"evt_5607989a08ad","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"10-K","fp":"842913a70acda326","kind":"sec_filing","published_at":"20260415","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.7,"dates_mentioned":["2026-04-16T02:08:52.472606+00:00","As of June 30, 2025"],"entities":[{"asset_class":"equity","name":"Traws Pharma, Inc.","relevance":"high","symbol":"TRAW","type":"issuer"}],"event_type":"listing","information_gaps":["No explicit statement of the fiscal year/period covered by the 10-K is present in the provided cleaned text.","No financial statements, revenue/earnings figures, cash/liquidity amounts, or risk-factor specifics are included in the provided text excerpt.","The signal is described as a \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or comparison details are provided, so \u201cwhat changed vs prior\u201d cannot be determined from the excerpt.","The cover-page fields that appear truncated (e.g., aggregate market value amount) are missing values in the provided text."],"key_facts":["The document is an SEC Form 10-K for Traws Pharma, Inc.","The filing includes standard 10-K cover-page checkboxes and disclosures (e.g., shell company indicator, incorporation by reference to proxy statement).","The filing contains a section titled \u201cSPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS AND INDUSTRY DATA.\u201d"],"numeric_claims":[],"primary_claim":"Traws Pharma, Inc. filed a Form 10-K with the SEC (filed 2026-04-16 per the provided filing_date).","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Traws Pharma, Inc. filed an annual report on Form 10-K with the SEC. The provided text is largely boilerplate and does not include specific financial or business results.","topics":["SEC filing","Form 10-K","forward-looking statements","corporate reporting"]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 10-K \u00b7 Traws Pharma, Inc. \u00b7 Filed 20260415","ticker":"TRAW","tickers":["TRAW"],"title":"TRAW filed 10-K","url":"https://www.sec.gov/Archives/edgar/data/1130598/0001104659-26-043832.txt"}}... |